Accretion Nutraveda IPO Allotment Status Online

The Accretion Nutraveda IPO allotment status will be available on the allotment date on February 2, 2026, Monday. The Accretion Nutraveda IPO subscription was ended on January 30, 2026, Friday.

The investors who applied for the IPO will be able to check the Accretion Nutraveda IPO allotment status online on the Kfin Technologies Ltd. website or the BSE website. The IPO was subscribed [.] times overall. The IPO GMP went around ₹0 level after the subscription ended.

Accretion Nutraveda IPO

Table of Contents

Accretion Nutraveda IPO Allotment Date

As per the timeline, the Accretion Nutraveda IPO allotment date is February 2, 2026, Monday. The investors can check the IPO allotment via the registrar website of KfinTech or the BSE website. Investors can check the allotment status online and offline with easy steps given below:

Registrar:KfinTech IPO Allotment Page
BSE: BSE IPO Allotment Page
IPO Watch:IPO Allotment Status Page

Check Accretion Nutraveda’ IPO Allotment Status on Registrar site?

  1. Visit KfinTech Services Pvt. Ltd. website
  2. Select IPO Name ‘Accretion Nutraveda’ from the drop-down menu on the page
  3. Enter details required like PAN Card, Application Number, or Demat Account Number
  4. Click on the ‘Search’ Button, and;
  5. Get your allotment on the your screen

Check Accretion Nutraveda IPO Allotment Status on BSE?

  1. Visit BSE India IPO Allotment Page
  2. Select the issue type: equity/debt
  3. Select IPO Name ‘Accretion Nutraveda’ from the drop-down menu on the page
  4. Enter details required like PAN Card or Application Number
  5. Click on the ‘Search’ Button, and;
  6. Get your allotment on the your screen

IPO Subscription Details

CategoryDay 1Day 2Day 3
QIB
NII
RII
Total

Accretion Nutraveda IPO Key Dates

IPO Open Date:January 28, 2026
IPO Close Date:January 30, 2026
Basis of Allotment:February 2, 2026
Refunds:February 3, 2026
Credit to Demat Account:February 3, 2026
IPO Listing Date:February 4, 2026

Business Overview

Accretion Nutraveda, since its incorporation in 2021, has been focused on the manufacturing of Ayurvedic and Nutraceutical products in India. It offers Ayurvedic and Nutraceutical products in various dosages and forms, like tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels.

The company serves its customers in India as well as in international countries like Sri Lanka, Singapore, and the USA. The firm blends Ayurvedic and science to offer treatments for various areas, like liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness. The company runs a 10,763 sq. ft. manufacturing facility situated in Gujarat. Its unit includes modern infrastructure and quality control systems.

Note for the Investors

Accretion Nutraveda IPO Registrar is responsible for the IPO allotment and refund process. If you have any queries regarding the Accretion Nutraveda IPO Allotment date and time please contact the registrar with your queries.

Accretion Nutraveda IPO Allotment Status FAQs


When is Accretion Nutraveda IPO Allotment Date?

Accretion Nutraveda IPO Allotment is to be available on February 2, 2026, Monday.

What will be Accretion Nutraveda IPO Refund Date?

The IPO refund date is February 3, 2026, Tuesday.

How to check the Accretion Nutraveda IPO Allotment Status?

Check Accretion Nutraveda IPO allotment status via your PAN number, the application number, or the amount deducted in your bank.

Founder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *